|
US6004924A
(en)
|
1991-12-11 |
1999-12-21 |
Imperial Cancer Research Technology, Ltd. |
Protein sequences of serrate gene products
|
|
US5869282A
(en)
*
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
|
US5786158A
(en)
*
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
EP0861261B9
(en)
|
1995-06-28 |
2010-02-24 |
Imperial Cancer Research Technology Limited |
Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
|
|
US5780300A
(en)
*
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
WO1997045143A1
(en)
*
|
1996-05-31 |
1997-12-04 |
The National American Red Cross |
Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
|
|
US6136952A
(en)
*
|
1997-06-25 |
2000-10-24 |
University Of Washington |
Human jagged polypeptide, encoding nucleic acids and methods of use
|
|
AU1054900A
(en)
*
|
1998-10-30 |
2000-05-22 |
Smith & Nephew Plc |
Compositions comprising notch receptor manipulating agents
|
|
US20030196885A1
(en)
*
|
1999-05-17 |
2003-10-23 |
Marchitto Kevin S. |
Electromagnetic energy driven separation methods
|
|
FR2798674B1
(fr)
*
|
1999-09-21 |
2004-01-30 |
Mahmood Salman Al |
Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
|
|
DE60124380T2
(de)
*
|
2000-03-22 |
2007-10-11 |
Curagen Corp., New Haven |
Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
WO2002018544A2
(en)
*
|
2000-08-31 |
2002-03-07 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
|
WO2003011317A1
(en)
*
|
2001-07-25 |
2003-02-13 |
Lorantis Limited |
Modulators of notch signalling for use in immunotherapy
|
|
GB0118223D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Univ Sheffield |
Stem loop RNA
|
|
WO2004078944A2
(en)
|
2003-03-05 |
2004-09-16 |
Maine Medical Center Research Institute |
Thrombin, soluble jaggedi, and trap and growth of stem cells
|
|
US20060084599A1
(en)
*
|
2003-03-05 |
2006-04-20 |
Maine Medical Center |
Compositions, methods and kits relating to notch signaling
|
|
WO2005014854A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Licentia, Ltd. |
Materials and methods for colorectal cancer screening, diagnosis, and therapy
|
|
CA2554779A1
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
US7794742B2
(en)
*
|
2005-02-08 |
2010-09-14 |
University Of Washington |
Devices for promoting epithelial cell differentiation and keratinization
|
|
WO2006125001A2
(en)
*
|
2005-05-17 |
2006-11-23 |
Maine Medical Center Research Institute |
Compositions and methods related to the intracellular effects of intracellular domains of delta1 and jagged1
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
WO2007053648A2
(en)
|
2005-10-31 |
2007-05-10 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
ES2641087T3
(es)
|
2005-10-31 |
2017-11-07 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para el diagnóstico y el tratamiento del cáncer
|
|
EP1998785A4
(en)
*
|
2006-02-21 |
2009-06-17 |
Univ Michigan |
TREATMENT OF CANCER BY AN ANTAGONIST OF THE HEDGEHOG SIGNALING PATH
|
|
ES2413087T3
(es)
|
2006-06-13 |
2013-07-15 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para el diagnóstico y tratamiento del cáncer
|
|
JP5618544B2
(ja)
|
2007-01-24 |
2014-11-05 |
オンコメッドファーマシューティカルズ インコーポレイテッド |
癌の診断および処置のための組成物および方法
|
|
US8148147B2
(en)
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
WO2008100563A2
(en)
*
|
2007-02-14 |
2008-08-21 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
US7998110B2
(en)
*
|
2007-04-25 |
2011-08-16 |
Hong Kong Polytechnic University |
Medical device for delivering drug and/or performing physical therapy
|
|
WO2008140826A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
ME02069B
(me)
|
2008-07-08 |
2015-05-20 |
Oncomed Pharm Inc |
Vezujuci agensi notch1 receptora i postupci njihove primene
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
BRPI0919473A2
(pt)
|
2008-09-26 |
2017-08-29 |
Oncomed Pharm Inc |
Agentes de ligação frizzled e usos dos mesmos
|
|
US8945569B2
(en)
|
2009-11-19 |
2015-02-03 |
Oncomed Pharmaceuticals, Inc. |
Jagged-binding agents and uses thereof
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
MX2012008085A
(es)
|
2010-01-13 |
2012-09-12 |
Oncomed Pharm Inc |
Agentes de union notch1 y metodos de uso de los mismos.
|
|
EP2552953B1
(en)
|
2010-04-01 |
2017-05-17 |
OncoMed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
AU2011336707A1
(en)
*
|
2010-11-29 |
2013-07-04 |
Dako Denmark A/S |
Methods and systems for analyzing images of specimens processed by a programmable quantitative assay
|
|
EP2863948B1
(en)
|
2012-06-22 |
2018-10-24 |
Cytomx Therapeutics Inc. |
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
|
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
|
CN105073195A
(zh)
|
2013-02-04 |
2015-11-18 |
昂科梅德制药有限公司 |
使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
CN104761622A
(zh)
*
|
2015-03-31 |
2015-07-08 |
苏州普罗达生物科技有限公司 |
关于Jaggedl激动剂多肽及其应用
|
|
CN104693278A
(zh)
*
|
2015-03-31 |
2015-06-10 |
苏州普罗达生物科技有限公司 |
一种Jaggedl激动剂多肽及其应用
|
|
CN104672313A
(zh)
*
|
2015-03-31 |
2015-06-03 |
苏州普罗达生物科技有限公司 |
Jaggedl激动剂多肽及其应用
|